Jason Haas

Insider Reports History

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Haas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Director Common Stock 5.4K $468K $86.65 Jun 14, 2024 Direct
Syros Pharmaceuticals, Inc. Chief Financial Officer Common Stock 0 $0 $2.09 Nov 18, 2024 Direct
Syros Pharmaceuticals, Inc. Chief Financial Officer Restricted Stock Units 0 $0 $2.09 Oct 31, 2024 Direct
LIGAND PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 5.44K Jun 14, 2024 Direct

Insider Reports Filed by Jason Haas

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Nov 18, 2024 1 -$29K 4 Nov 20, 2024 Chief Financial Officer
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2024 3 -$11.8K 4 Nov 4, 2024 Chief Financial Officer
SYRS Syros Pharmaceuticals, Inc. Sep 10, 2024 3 $161K 4 Sep 12, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Jun 14, 2024 2 $0 4 Jun 18, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2024 5 -$24.2K 4 Apr 2, 2024 Chief Financial Officer
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2023 3 -$14K 4 Nov 2, 2023 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Jun 9, 2023 2 $0 4 Jun 13, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2023 3 -$1.61K 4 Apr 4, 2023 Chief Financial Officer
SYRS Syros Pharmaceuticals, Inc. Feb 16, 2023 1 $0 4 Feb 21, 2023 Chief Financial Officer
SYRS Syros Pharmaceuticals, Inc. Oct 6, 2022 2 $0 4 Oct 11, 2022 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Jun 29, 2022 2 $0 4 Jun 30, 2022 Director
LGND LIGAND PHARMACEUTICALS INC Jun 29, 2022 0 $0 3 Jun 29, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Feb 15, 2022 2 $0 4 Feb 17, 2022 Chief Financial Officer
SYRS Syros Pharmaceuticals, Inc. Oct 12, 2021 1 $0 4 Oct 13, 2021 Chief Financial Officer
SYRS Syros Pharmaceuticals, Inc. Oct 12, 2021 0 $0 3 Oct 13, 2021 Chief Financial Officer